Tolga Han Efe

Tolga Han Efe

Auto-generated profile, based on publicly available information

Tolga Han Efe

Department of Cardiology, Ankara Etlik City Hospital, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2016 in Echocardiography
Verified
Journal Article
Closed access
PDF file
TETolga Han Efe
Tolga Han Efe
TCTolga Cimen
Tolga Cimen
AEAhmet Goktug Ertem
Ahmet Goktug Ertem
YCYusuf Coşkun
Yusuf Coşkun
MBMurat Bilgin
Murat Bilgin
EYEkrem Yeter
Ekrem Yeter

14 April 2023 in Arrhythmia and Electrophysiology Review
Verified
Journal Article
Open access
PDF file
DSDavid Schaack
David Schaack
BSBoris Schmidt
Boris Schmidt
STShota Tohoku
Shota Tohoku
SBStefano Bordignon
Stefano Bordignon
LULukas Urbanek
Lukas Urbanek
KCKr Julian Chun
Kr Julian Chun
Catheter ablation is a widely used, effective and safe treatment for AF. Pulsed field ablation (PFA), as a novel energy source for cardiac ablation, has been shown to be tissue selective and is expected to decrease damage to non-cardiac tissue while providing high efficacy in pulmonary vein isolation. The FARAPULSE ablation system (Boston Scientific) follows the idea of single-shot ablation and is the first device approved for clinical use in Europe. Since its approval, multiple high-volume centres have performed increasing numbers of PFA procedures in patients with AF and have published their experiences. This review summarises the current clinical experience regarding the use of PFA for AF using the FARAPULSE system. It provides an overview of its efficacy and safety.

1 November 2016 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
TETolga Han Efe
Tolga Han Efe
KYKadriye Gayretli Yayla
Kadriye Gayretli Yayla
CYCagri Yayla
Cagri Yayla
AEAhmet Goktug Ertem
Ahmet Goktug Ertem
TCTolga Cimen
Tolga Cimen
EYEkrem Yeter
Ekrem Yeter
Calcific aortic valve disease, a chronic progressive disorder, is the leading cause of valve replacement among elderly patients. The lymphocyte/monocyte ratio has been recently put forward as an inflammatory marker of relevance in several cancers as well as in cardiovascular disease. This study aims to assess the correlation between severity of calcific aortic stenosis and the lymphocyte/monocyte ratio. The study retrospectively included 178 patients with a diagnosis of calcific aortic stenosis and 139 age- and gender-matched controls. The patients were divided into two groups according to the severity of aortic stenosis: mild-to-moderate and severe. An inverse correlation was discerned between the severity of the aortic stenosis process (mean gradient) and the lymphocyte/monocyte ratio (r=-0.232, p=0.002). The lymphocyte/monocyte ratio was observed to decrease as the severity of aortic stenosis increased (p<0.001) in the group with severe aortic stenosis compared with the mild-to-moderate aortic stenosis and control groups (p<0.001, p=0.005 respectively), and in the group with mild-to-moderate aortic stenosis compared with the control group (p=0.003). Multivariate regression analysis revealed that the lymphocyte/monocyte ratio was independently related to the severity of calcific aortic stenosis (p=0.003). The present study demonstrated the existence of a statistically significant inverse relationship between severity of calcific aortic stenosis and the lymphocyte/monocyte ratio. The study also revealed that the lymphocyte/monocyte ratio was significantly related to the severity of the aortic valve stenosis process.

1 February 2016 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
TETolga Han Efe
Tolga Han Efe
AEAhmet Goktug Ertem
Ahmet Goktug Ertem
YCYusuf Coşkun
Yusuf Coşkun
MBMurat Bilgin
Murat Bilgin
EAEngin Algul
Engin Algul
EYEkrem Yeter
Ekrem Yeter

28 April 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
SBStefano Bordignon
Stefano Bordignon
IMIlaria My
Ilaria My
STShota Tohoku
Shota Tohoku
ARAndreas Rillig
Andreas Rillig
DSDavid Schaack
David Schaack
BSBoris Schmidt
Boris Schmidt
Aims: A novel irrigated radiofrequency (RF) balloon (RFB) for pulmonary vein (PV) isolation (PVI) was released in selected centres. We pooled the procedural data on efficacy and safety of RFB-PVI from two high volume German centres. Methods and results: Consecutive patients with RFB procedures were enrolled. A 3D electroanatomical left atrial map guided the RFB navigation. Every RF delivery lasted 60 s, and duration was automatically reduced to 20 s for electrodes facing the posterior wall. Procedural data and post-procedural endoscopy data (<48 h) were analysed. Data from 140 patients were collected (57% male, 67 ± 11 years, 57% paroxysmal atrial fibrillation). There were 547 PVs identified, and 99.1% could be isolated using solely the RFB. Single-shot PVI was recorded in 330/547 (60%) PVs. Median time to isolation during the first application was 10 s (IQR 8–13). A total of 2.1 ± 1.8 applications per PV were delivered, with the left superior PV requiring more application compared to other PVs. Median procedure and fluoroscopy time were 77 min (61–99) and 13 min (10–17), respectively. Major safety events were recorded only in the first 25 cases at each centre and included 1/140(0.7%) cardiac tamponade, 1/140(0.7%) phrenic nerve palsy, and 2/140 strokes (1.4%). An oesophageal temperature rise was recorded in 81/547 (15%) PVs, and endoscopy detected oesophageal lesions in 7/85 (8%) patients undergoing endoscopy. Conclusion: The RFB showed a high efficacy allowing for fast PVI procedures, and 60% of PVs could be isolated at the first application. Most safety events were recorded during the learning phase. An oesophageal temperature monitoring is suggested: oesophageal lesions were detected in 8% of patients.

1 February 2017 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
TÇTolga Çimen
Tolga Çimen
HSHamza Sunman
Hamza Sunman
TETolga Han Efe
Tolga Han Efe
MEMehmet Erat
Mehmet Erat
HŞHaluk Furkan Şahan
Haluk Furkan Şahan
EYEkrem Yeter
Ekrem Yeter
The neutrophil-to-lymphocyte ratio (NLR) is established as a reliable marker of systemic inflammation. Low-grade inflammation has a key role in the pathogenesis and progression of hypertension (HTN). Blood pressure (BP) load, defined as the percentage of abnormally elevated BP readings, is a good marker of HTN severity. We aimed to evaluate the relationship between HTN severity and NLR using averaged ambulatory BP readings and BP load. A total of 300 patients with untreated essential HTN were included in this cross-sectional study. Patients were divided into quartiles according to NLR values (first: 2.48). Averaged ambulatory BP values and BP load were assessed for each quartile. In the interquartile evaluation there were no differences between quartiles in terms of baseline demographic, clinical and echocardiographic characteristics (p>0.05). Daytime systolic BP (SBP), 24-hour diastolic BP (DBP), daytime DBP, daytime SBP load, 24-hour DBP load and daytime DBP load were found to be significantly higher in the upper two quartiles (p<0.05 for all). In correlation analysis, log NLR values were found to be positively correlated with 24-hour SBP, DBP, SBP load and DBP load (Pearson coefficients of 0.194, 0.197, 0.157 and 0.181, respectively; p<0.01 for all). In multivariate analysis, log NLR had an independent association with 24-hour SBP and DBP and 24-hour SBP and DBP load. This study showed for the first time that increased NLR is independently associated with HTN severity in untreated essential HTN patients.